Working across the oncology translation pathway 

Apex Science works alongside organisations bringing cancer research from discovery to clinical application.

This includes partnering with medical research charities to clarify research priorities and guide research investment decisions, and supporting early-stage life sciences companies preparing oncology programs for funding, partnership, and clinical trials.

Across this pathway, the focus is consistent: ensuring scientific, translational, and funding decisions are grounded in biological reality and aligned with a credible path to patient impact.

Support is typically provided at key transition points in the oncology translation pathway, including:

• defining research priorities and investment focus

• preparing programs for grant, philanthropic, or investor funding

• assessing translational readiness of oncology programs

• planning translational development and clinical trial pathways

• strengthening scientific input to board and executive decisions

These moments often shape the long-term direction of oncology research programs, portfolios, and companies.

Work is collaborative, science-led, and tailored to the organisation and decision context.

Apex Science works directly with clinicians, researchers, executives, founders, and funders, often across multiple organisations , to connect scientific evidence, translational planning, and funding strategy.

The goal is not to introduce process, but to strengthen clarity, alignment, and confidence in the decisions being made.

Engagements usually begin with a small number of focused conversations to clarify the scientific, translational, and strategic context of the decision.

From there, work may include:

• reviewing research programs or funding proposals

• mapping translational pathways and development sequencing

• clarifying milestones and decision points

• preparing programs for funding, partnership, or clinical trials

• providing ongoing scientific advisory support where needed

Engagements are typically fixed-scope, founder-led, and designed to support real decisions within defined timeframes.